6 completed, 5 recruiting, 2 active not recruiting, 1 not yet recruiting. 9 Not applicable, 2 Phase 1, 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 4, Recruiting 3, Active not recruiting 1, Not yet recruiting 1 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Recruiting 2 |
| Early Phase 1 | 1 | Completed 1 |
Follow Placebo Capsule(s): new trials by email Literature Review of Placebo Capsule(s) trials Research Report on Placebo Capsule(s)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplantation in Females With Anorexia Nervosa Fecal Microbiota Transplantation Capsule, Placebo Capsule(s) - Anorexia Nervosa | Not applicable | Not yet recruiting | Andreas Munk Petersen | 60 | 2026-11-16 | 2026-10-16 |
| Bempedoic Acid Therapy for Polycystic Kidney Disease Bempedoic Acid 180 MG Oral Tablet, Placebo Capsule(s) - ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Phase 2 | Recruiting | Kenneth Hallows | 120 | 2026-09-01 | 2026-09-29 |
| Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness Lactobacillus casei, Placebo Capsule(s) - Exercise Induced Muscle Damage, Delayed Onset Muscle Soreness (DOMS) | Not applicable | Recruiting | University of Minnesota | 24 | 2026-02-05 | 2026-05-04 |
| Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females Lactiplantibacillus plantarum 299v, Placebo Capsule(s) - Iron Deficiency (ID), Pregnancy | Phase 2 | Recruiting | University of Illinois at Chicago | 250 | 2026-02-01 | 2026-05-01 |
| Effect of Psychobiotics With Standard Antiddepressants in Treatment of Major Depressive Disorder Lactobacillus Helveticus and bifidobacterium Longum, Placebo Capsule(s) - Major Depression | Not applicable | Recruiting | Dr Sadia yasir | 86 | 2026-01-31 | 2026-09-30 |
| Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms Bifidobacterium longum BBH016, Placebo Capsule(s) - Lower Abdominal Pain, Diarrhea | Not applicable | Active not recruiting | Seoul National University Bundang Hospital | 88 | 2025-08-01 | 2026-03-20 |
| Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women" KSM-66 Ashwagandha® capsule, Placebo Capsule(s) - Skin Health, Hair Health | Not applicable | Recruiting | SF Research Institute, Inc. | 50 | 2025-07-11 | 2025-10-15 |
| Multivitamin for Health and Cognition Placebo Capsule(s), multivitamin - Healthy, Cognition | Not applicable | Completed | Dr Anthony Hobson | 37 | 2025-07-07 | 2026-03-11 |
| Aging Resilience Through Microbiota Optimization and Regulation FMT capsule, Placebo Capsule(s) - Resilience, Cognitive Function and Well-Being | Phase 1 | Active not recruiting | Gonzalo Jorquera, PhD | 80 | 2025-01-10 | 2026-07-29 |
| The Impact of Vitamin D Supplementation in Hypertensive Vitamin D Deficient Patients. Vitamin D (Cholecalciferol ), Placebo Capsule(s) - Hypertension, Vitamin D Deficiency | Not applicable | Completed | University of Sulaimani | 60 | 2024-11-16 | 2025-08-15 |
| Curcumin, Vitamin D and Green Tea in IBS-D Curcumin, vitamin d and green tea extract, Placebo Capsule(s) - Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D) | Not applicable | Completed | Dr Anthony Hobson | 78 | 2024-09-19 | 2026-03-11 |
| Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients. Short Chain Fatty Acid, Placebo Capsule(s) - Metabolic Effects, Immunosuppressive Agents | Not applicable | Completed | University Hospital, Martin | 41 | 2024-01-15 | 2025-06-12 |
| Neurocognitive Effects of Extended-Release Methylphenidate in Healthy Adults Methylphenidate Stimulant medication therapy, Placebo Capsule(s) - Healthy Adult Male and Female Volunteers | Early Phase 1 | Completed | University of Witwatersrand, South Africa | 30 | 2023-02-06 | 2026-08-03 |
| A Study of LY2940680 in Healthy Participants LY2940680 Capsule(s) (Reference), LY2940680 Tablet (Test), Lansoprazole - Healthy Participants | Phase 1 | Completed | Eli Lilly and Company | 30 | 2012-09-01 | 2019-10-21 |
Irritable Bowel Syndrome (2) · Anorexia Nervosa (1) · Depressive Disorder, Major (1) · Diarrhea (1) · Feeding and Eating Disorders (1) · Hypertension (1) · Insulin Resistance (1) · Iron Deficiencies (1) · Polycystic Kidney, Autosomal Dominant (1) · Vitamin D Deficiency (1)
Dr Anthony Hobson (2) · Andreas Munk Petersen (1) · Dr Sadia yasir (1) · Eli Lilly and Company (1) · Gonzalo Jorquera, PhD (1) · Kenneth Hallows (1) · SF Research Institute, Inc. (1) · Seoul National University Bundang Hospital (1) · University Hospital, Martin (1) · University of Illinois at Chicago (1) · University of Minnesota (1) · University of Sulaimani (1) · University of Witwatersrand, South Africa (1)
United States (5) · United Kingdom (2) · Chile (1) · Denmark (1) · Iraq (1) · Pakistan (1) · Slovakia (1) · South Africa (1) · South Korea (1)
Andreas Munk Petersen, Professor, MD, PhD, DMSc (1) · Anthony Hobson, PhD (1) · Arooj Fatima (1) · Dana Miskulin, MD (1) · Darya S. Abdulateef, Ph.D. (1) · Dennis Sandris Nielsen, Professor, MSc, PhD (1) · Dorte Bonde Zilstorff, MD (1) · Gonzalo Jorquera, PhD (1) · Ingrid Maria Cecilia Rubin, Associate professor, MD, PhD (1) · Kenneth Klingenberg Barfod, Associate Professor, MSc, PhD (1) · Kenneth R Hallows, MD, PhD, FASN (1) · Mary Stenson (1) · Morten Helms, MD, PhD (1)